(Q34227791)
Statements
1 reference
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer (English)
1 reference
Jorge Franco
1 reference
Agnieszka K Witkiewicz
1 reference
Erik S Knudsen
1 reference
1 reference
1 reference